ProKidney to Present at the J.P. Morgan 41st Annual Healthcare Conference
WINSTON-SALEM, N.C., Dec. 22, 2022 (GLOBE NEWSWIRE) — ProKidney Corp. (Nasdaq:PROK) (“ProKidney”), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced that Dr. Tim Bertram, Chief Executive Officer, will present at the J.P. Morgan 41st Annual Healthcare Conference in San Francisco on Wednesday, January 11th, 2023, at 3:45 PM PT.
Related news for (PROK)
- Breaking News: MoBot’s Latest Update as of 09/11/25 10:00 AM
- Today’s Top Performers: MoBot’s Market Review 08/04/25 02:00 PM
- Today’s Top Performers: MoBot’s Market Review 08/04/25 01:00 PM
- ProKidney Announces Alignment with the FDA on the Accelerated Approval Pathway for Rilparencel
- MoBot’s Stock Market Highlights – 07/15/25 08:00 AM